AMADEUS4-1: Sarcopenia study
- Conditions
- All cancer patients
- Registration Number
- JPRN-jRCT1030220014
- Lead Sponsor
- Iwata Shintaro
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
1) All cancer patients scheduled for initial treatment at the study site.
2) Patients aged between 16 and 39 years at the time of consent.
3) Written consent has been obtained from the individual (if the research subject is a minor 16 years of age or older, written consent should be obtained from a surrogate in addition to the individual).
1) Patients who cannot be assessed for their ambulance status due to poor general condition.
2) Patients deemed inappropriate by the principal investigator.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method